Disintegration Time Research Articles

Design and Development of Propranolol HCl Fast Dissolving Tablets by Using Isolated Mucilage of Salvia Hispanica for the Treatment of Hypertension by Using DoE tools.

The main issue with Hypertension therapy is quick commencement of effect. The creation of suitable dose forms may help address the issue of medications having a delayed beginning of effect. Oral Antihypertensive medication treatment is best suited for and has seen a rise in popularity with fast-disintegrating tablets. In terms of patient compliance, quick start of action, precise dosage, strong chemical stability, ease of self-administration, and compactness, they are superior to other traditional methods. As a popular hypertension medication, Propranolol HCl is a strong candidate for development into Fast Dissolving Tablets (FDTs). Because to first pass metabolism, it has a limited bioavailability. Therefore, the primary goal of the research was to create Propranolol HCl fast-dissolving tablets in order to increase the drug's bioavailability and dissolution rate. Microcrystalline cellulose used to make fast-dissolving Propranolol HCl tablets, together with varying concentrations of super disintegrates such as Chia Seed mucilage and sodium starch glycolate. Each batch was made by compressing it directly. Three formulation variables were combined, and the combined impact was examined using a 23 Full Factorial design. Here, the disintegration time is examined as a dependent parameter and the concentrations of chia seed mucilage, Sodium Starch Glycolate, and Microcrystalline Cellulose were considered as independent variables, X1, X2, and X3, respectively. The program Design Expert is used to depict the data.

Effect of kyron T-134 and crospovidone as a fast disintegrating agent on formulation properties of fast dissolving tablet containing ketorolac and rizatriptan using direct compression method

Background and objective: Fast dissolving tablets (FDTs) are "they are uncoated tablets that are supposed to be placed in the mouth and dispersed quickly before being swallowed" within minutes. This study aimed to formulate and evaluate a combination of ketorolac and rizatriptan as orally fast-dissolving tablets using the most common and easiest method to treat migraine attacks with or without aura. To investigate the effects of various types of diluents and super disintegrants on wetting time, water absorption ratio, disintegration, and dissolution time of combined drugs (ketorolac and rizatriptan) as oral dissolving tablets prepared by direct compression technique. Methods: Pre-formulation experiments were carried out in order to rule out any physicochemical interactions between the two medications (ketorolac and rizatriptan) as well as between each drug and its excipients. Four different formulations of fast-dissolving tablets with different types and ratios of diluents and super disintegrants were created using the direct compression technique in order to improve the formulation. Organoleptic characteristics, weight variation, thickness, friability, hardness, disintegration duration, wetting duration, water absorption ratio, drug content, in-vitro dissolution, stability, and comparison tests have all been characterized. Results: According to FT-IR, the two drugs and excipients exhibit no physicochemical interactions. The ideal formula F4 contains crospovidone and Kyron T-134 at optimal concentrations of 2.5% and 2.5%, respectively, and provides the majority of pharmaceutical drugs to be released within the first five minutes, a strong stability profile, the shortest wetting time with the fastest disintegration time (10 sec), and a pleasant flavor (strawberry flavoring agent). Conclusion: Kyron T-134 with Crospovidone in a (1:1) ratio provided rapid disintegration. Ketorolac tromethamine and rizatriptan benzoate may be made into fast-dissolving oral tablets using Kyron T-134 and Crospovidone. Improving migraine compliance is a reasonable goal.

Optimization of /locel 101 and Amylum as /illers in Sambiloto (Andrographis paniculata (Burm.f.) Nees.) Capsules /ormulation

Sambiloto (Andrographis paniculata (Burm.f.) Nees.) is an herbal plant that is beneficial for health due to its main chemical component, andrographolide. Sambiloto can be formulated into capsules to make it more practical and comfortable for consumption, mask the bitter taste, and guarantee dosage accuracy. This research aimed to determine the optimal concentration of Flocel 101 and amylum as capsule fillers to achieve the best physical properties of Sambiloto extract capsules. The study was conducted experimentally using 5 (five) formulas (F1, F2, F3, F4, and F5) with various concentrations of Flocel 101 and amylum. A series of tests were conducted on the physical properties of the capsule powder: organoleptic tests, water content, flowability, disintegration time, and average capsule weight. Additionally, quality control was performed by checking for microbial contamination through total plate count (TPC) and yeast and mold count (YMC) tests. The results of this research indicated that the F1 formula provided the best physical properties and met the requirements, with the appearance of a greenish-gray dry powder, water content of 6.88%, flow rate of 20 g/s, disintegration time of 15.5 minutes, average weight of 0.55 g, TPC 250 cfu/g, and YMC <10 cfu/g.

Formulation and evaluation of melatonin as fast dissolving oral strips using combined polymers

Background and objective: Fast-dissolving oral thin film (FDOF) is a novel and most advanced form of solid dosage form that dissolves or disintegrates in 1 minute when put in the mouth without water or chewing. Pre-gastric absorption of FODFs from the mouth, pharynx, and esophagus as saliva flows down into the stomach would improve the therapeutic benefit of the drug as oral films disintegrated in the mouth. The study is designed and purposed to use most water soluble, best type and concentration of polymers to be selected for use in combination to formulate melatonin oral thin films. Different types of synthetic water soluble polymers were utilized the preparation of films (hydroxypropyl methyl cellulose HPMC15M, sodium carboxy methyl cellulose NACMC). Methods: Solvent casting method was performed for preparation of twelve placebo films at the beginning, to obtain and select suitable polymer type and concentration for use in combination to be formulated for drug loading. The films were evaluated for their characteristics like mechanical properties (thickness and folding endurance), surface pH and disintegration time. Percentage of release and assay of melatonin was taken. Comparison studies were performed on melatonin films from this study with melatonin oral disintegrating tablets release profiles. Best batch could be selected. Drug-excipient compatibility carried out as pre formulation study to see whether there is interaction between the drug and excipients used. Results: Results from FT-IR showed no interaction between melatonin and polymers used, the prepared formulations were clear, transparent, non-sticky and easily removed from the plate surface with the thickness ranging from (0.04-0.07) mm depending on the polymer concentration. The times required for the films to disintegrate was ranging from 21-26 seconds, and the majority of melatonin was released within first 2 minutes within the dosage form. Conclusion: Melatonin can be formulated as fast dissolving oral films using combination of water-soluble polymers by solvent casting method to obtain ease of administration without using water during administration, fast onset of action resulted from rapid disintegration.

Effect of nano-fluorapatite filler particles on surface microhardness and mineralization capacity of an experimental oral film

BackgroundThe objective of the study was to prepare and assess novel remineralizing oral films loaded with fluorapatite powder and composed of a combination of hydroxyethyl cellulose (HC) and cellulose nanofibers (CF).MethodsThree concentrations of the prepared nano-fluorapatite were tried and tested after loading in the cellulose blends and films were prepared using solvent cast technique. Along with SEM, measurements of thickness of film, bending tolerance, time of disintegration, surface pH and release of ions were made. The produced film’s ability to remineralize demineralized teeth in vitro was investigated.ResultsThe findings showed that the films’ thicknesses were uniform, their folding endurance exceeded 300, and their disintegration times exceeded 24 h. High amounts of fluoride and calcium ions were released, and nearly neutral pH values were observed. The distribution of fluorapatite powder particles was uniform, as demonstrated by SEM. The Vickers microhardness (VHN) of enamel and morphological analysis results showed that in comparison with the demineralized specimens, there was a substantial microhardness value increase following 15 and 30 days remineralization.ConclusionsNewly developed prepared films are a successful method for remineralizing early-stage demineralized tooth lesions.

A data-driven approach to predict the in vitro dissolution time of sustained-release tablets using raw material databases and machine learning algorithms

Tablets are the most typical dosage forms of pharmaceutical inventions. Sustained-release (SR) tablet formulations are designed to release the drug gradually in the bloodstream and often require less frequent dosing. Current strategies to optimize sustained-release tablet dissolution time still rely on the traditional approach, which is time-consuming and expensive. In the present context, we have demonstrated alternate machine learning and deep learning models through the TPOT AutoML platform. Six machine learning (ML) models were compared to improve the methodology for dissolution time prediction, particularly the decision tree regressor (DTR), gradient boost regressor (GBR), random forest regressor (RFR), extra tree regressor (ETR), XGBoost regressor (XGBR), and deep learning (DL). The obtained results indicated that machine learning methods are convincing in speculating the dissolution time, especially the random forest regressor, but upon hypertuning of the deep neural network, the deep learning model with a 10-fold cross-validation scheme demonstrated superior predictive performance with an NRMSE of 8% and an R2 of 0.92. The major essentials affecting the dissolution time of SR tablets were explained using the SHAP method.

Formulation and optimization of olanzapine-carboxylic acid cocrystals orodispersible tablets: In-vitro/ In-vivo study

Oromucosal delivery of olanzapine (OLZ) is an optimal strategy to overcome low oral bioavailability as well as improve medication adherence. However, its poor aqueous solubility may hinder its absorption through the buccal mucosa. The aim of the study is to enhance OLZ solubility and dissolution via cocrystal formation, followed by incorporation into an orodispersible tablet (ODT) based on an effervescent mixture and crospovidone as a superdisintegrant mixture. OLZ was cocrystallized with different carboxylic acids using slow solvent evaporation, and the optimal cocrystal formula was subjected to solid state characterization. Central composite design (CCD) was used in the modeling and optimization of the ODT independent variables (amounts of crospovidone and effervescent mixture). The optimized OLZ cocrystal ODTs were subjected to microenvironmental pH, stability, and in-vivo studies. The results revealed that the OLZ:itaconic acid at 1:1 M ratio showed a 7.86 fold increase in OLZ solubility and 86.71 ± 1.07 % dissolution efficiency (DE60 %) with FTIR, XRPD, and DSC diffractograms that confirmed the cocrystal formation. The optimized OLZ cocrystal ODTs exhibited hardness of 3.6 ± 0.1 kg/cm2, disintegration time of 11.66 ± 1.52 s, wetting time of 36.33 ± 2.51 s, and 94.26 ± 2.77 % OLZ released within 15 min with a DE60 % of 91.65 ± 0.98 %. Finally, the optimized OLZ cocrystal ODTs showed a significant (p < 0.01) higher Cmax and AUC with a relative bioavailability of 139.08 % compared to the Schisolazine©10 mg ODTs. These results suggest that OLZ:itaconic acid cocrystal incorporated into an ODT containing a superdisintegrant mixture of effervescence mixture and crospovidone is a potential approach for enhancement of oromucosal delivery of OLZ.

Improvement of Bioavailability of Sildenafil Citrate Through Taste Masked Orodispersible Film for Pulmonary Hypertension Management.

The oral bioavailability of sildenafil citrate is approximately 43%, primarily limited by the low aqueous solubility and first-pass effect. Considering the drug properties and biopharmaceutical considerations, this study aimed to develop an immediate release, taste masked orodispersible film (ODF) of sildenafil citrate for the efficient management of pulmonary arterial hypertension (PAH). The optimization was done by applying 32 full-factorial design. The drug-loaded film was prepared and evaluated for the physical and mechanical parameters like; thickness, disintegration time, tensile strength, elongation, swelling index, content uniformity, disintegration and in vitro drug release in pH 6.2 stimulated salivary fluid. The FTIR and DSC data proved excellent compatibility between the drug and polymers used. The time taken for disintegration by the optimized film was about 62.66s, while the drug release was observed ~ 96% in 10min. Pharmacokinetic studies exhibited better sildenafil plasma level (p < 0.05) and Cmax (p < 0.001) of orally disintegrating film which is significantly higher than the oral drug solution. The AUC0-8 (24874.425 ± 1234.45ng. h/mL) in the oromucosal application was 1.2-fold more (p < 0.0001) than the control. The presence of sweetening and flavoring agents in the formulation masked the drug bitterness, resulting in a higher intake of the formulation in rats compared to the unmasked drug solution, as observed with in vivo taste masking studies. The importance of ODF as a feasible, effective, and optimal approach for delivering sildenafil citrate via oromucosal administration for the treatment of PAH was successfully highlighted by these results.

Oral Dissolution Therapy of Uric Acid Stones: A Systematic Review

Background/Objectives: Uric acid stones are the second most common type of kidney stones worldwide. Despite being cost-effective and widely available, pharmacological management for these stones is less utilized compared to surgical approaches. Therefore, we conducted a systematic review of the literature to assess the efficacy and shortcomings of oral dissolution therapy for uric acid stones. Methods: Embase, Scopus, PubMed, and Cochrane library databases were searched for English language studies on adults who were diagnosed with uric acid kidney stones and treated with oral dissolution therapy. Results: Twelve studies met our inclusion criteria. Potassium citrate was the primary agent used for dissolution in 10 of the studies and demonstrated a 50% or higher success rate for complete dissolution of uric acid stones. Treatment time for successful dissolution varied, with an average of 3 months minimum and an average of 2.78 years maximum. Overall, 11 of the studies recommended that oral dissolution therapy should be used for either treatment or prevention of uric acid stones. Conclusions: The available evidence demonstrates benefit of oral dissolution therapy for patients with uric acid stones. However, future rigorous studies are required to determine the optimal treatment regimen.

Tailored Sticky Solutions: 3D-Printed Miconazole Buccal Films for Pediatric Oral Candidiasis.

In this research, 3D-printed antifungal buccal films (BFs) were manufactured as a potential alternative to commercially available antifungal oral gels addressing key considerations such as ease of manufacturing, convenience of administration, enhanced drug efficacy and suitability of paediatric patients. The fabrication process involved the use of a semi-solid extrusion method to create BFs from zein-Poly-Vinyl-Pyrrolidone (zein-PVP) polymer blend, which served as a carrier for drug (miconazole) and taste enhancers. After manufacturing, it was determined that the disintegration time for all films was less than 10min. However, these films are designed to adhere to buccal tissue, ensuring sustained drug release. Approximately 80% of the miconazole was released gradually over 2h from the zein/PVP matrix of the 3D printed films. Moreover, a detailed physicochemical characterization including spectroscopic and thermal methods was conducted to assess solid state and thermal stability of film constituents. Mucoadhesive properties and mechanical evaluation were also studied, while permeability studies revealed the extent to which film-loaded miconazole permeates through buccal tissue compared to commercially available oral gel formulation. Histological evaluation of the treated tissues was followed. Furthermore, in vitro antifungal activity was assessed for the developed films and the commercial oral gel. Finally, films underwent a two-month drug stability test to ascertain the suitability of the BFs for clinical application. The results demonstrate that 3D-printed films are a promising alternative for local administration of miconazole in the oral cavity.

Formulation, Characterization, and In Vitro Simulated Gastrointestinal Fluid Analysis of Chewable Yogurt Tablet Incorporated with Corncob Fiber

This study formulates and evaluates a novel functional food, corncob fiber-infused chewable yogurt tablets, to enhance nutritional value. The tablets have the potential to alleviate gastrointestinal symptoms in the elderly and combat malnutrition in selective eaters, potentially replacing multiple supplement tablets. Four batches of tablets underwent rigorous evaluation, considering physicochemical properties, shelf life, and probiotic viability in simulated gastrointestinal conditions. All tablets exhibited robust stability against simulated fluids (85–90% survival rate) and met desired physicochemical benchmarks. Notably, F1 had the lowest hardness (9.50 kp/cm&lt;sup&gt;²&lt;/sup&gt;), while tensile strength showed no significant variance (0.93–1.18 N/mm&lt;sup&gt;²&lt;/sup&gt;) between tablets. However, F3 and F4 displayed significantly longer disintegration times (41.11–52.82 min). After three months, the average bacterial viability was 7 log no. CFU/g, highlighting the tablets’ potential to deliver intact probiotics for immediate beneficial effects upon consumption. Thus, these chewable yogurt tablets offer a promising means to deliver probiotics effectively while addressing specific dietary challenges.

Convective dissolution in a fractured porous matrix using multi-component surface reaction lattice Boltzmann method

In this paper, an improved lattice Boltzmann method-based surface reaction model for studying the convective dissolution of a multi-component system in porous matrix is propose. This model treats the generation and the consumption of components as a source term in control equation. The accuracy of the model is validated by comparing it with an analytical solution of a two-dimensional square cavity diffusion problem and achieves a good agreement. Subsequently, this model is applied to simulate the dissolution of porous medium with a triangular fissure on the surface. By investigating the aspect ratio of the fissure, the results reveal that a low base-height ratio can promote the dissolution rate. By investigating the main dimensionless number of Sc and Da, the results show that Schmidt number has a dominant influence on the dissolution process, and Da is positively correlated with the total dissolution time.

Development and Evaluation of a Dry Emulsion of Ostrich Oil as a Dietary Supplement.

This study aimed to develop a high-quality dry emulsion incorporating omega-3, 6, and 9 fatty acid-rich ostrich oil for use as a dietary supplement. Extracted from abdominal adipose tissues using a low-temperature wet rendering method, the ostrich oil exhibited antioxidant properties, favorable physicochemical properties, microbial counts, heavy metal levels, and fatty acid compositions, positioning it as a suitable candidate for an oil-in-water emulsion and subsequent formulation as a dry emulsion. Lecithin was employed as the emulsifier due to its safety and health benefits. The resulting emulsion, comprising 10% w/w lecithin and 10% w/w ostrich oil, was stable, with a droplet size of 3.93 ± 0.11 μm. This liquid emulsion underwent transformation into a dry emulsion to preserve the physicochemical stability of ostrich oil, utilizing Avicel® PH-101 or Aerosil® 200 through a granulation process. Although Aerosil® 200 exhibited superior adsorption, Avicel® PH-101 granules surpassed it in releasing the ostrich oil emulsion. Consequently, Avicel® PH-101 was selected as the preferred adsorbent for formulating the ostrich oil dry emulsion. The dry emulsion, encapsulated with a disintegration time of 3.11 ± 0.14 min for ease of swallowing, maintained microbial loads and heavy metal contents within acceptable limits. Presented as granules containing butylated hydroxytoluene, the dry emulsion showcased robust temperature stability, suggesting the potential incorporation of animal fat into dry emulsions as a promising dietary supplement.

Three-Dimensional Printing of PVA Capsular Devices for Applications in Compounding Pharmacy: Effect of Design Parameters on Pharmaceutical Performance.

The creation of products with personalized or innovative features in the pharmaceutical sector by using innovative technologies such as three-dimensional (3D) printing is particularly noteworthy, especially in the realm of compounding pharmacies. In this work, 3D printed capsule devices (CDs) with different wall thicknesses (0.2, 0.3, 0.4, 0.6, and 0.9 mm) and sizes were designed and successfully fabricated varying printing parameters such as extrusion temperature, printing speed, material flow percent, and nozzle diameter. The physicochemical, pharmaceutical, and biopharmaceutical performance of these CDs was evaluated with the aim of achieving an immediate drug release profile comparable to hard gelatin capsules (HGC) for use in magistral compounding. It was observed that the disintegration time of the CDs increased with wall thickness, which correlated with a slower drug release rate. CDs with configurations presenting 0.4 mm wall thickness and sizes comparable to HGC n° 0, 1, and 2 demonstrated satisfactory weight uniformity, short disintegration times, and immediate drug release, indicating their potential as effective devices in future compounding pharmacy applications. In addition, a modified Weibull-type model was proposed that incorporates wall thickness as a new variable in predicting dissolution profiles. This model improves the process of selecting a specific wall thickness to achieve the desired dissolution rate within a specified time frame.

Optimization of Effervescent Tablets in Sensory Acceptance from the Active Ingredients of Fish Protein Hydrolysate and Microalgae Chlorellae sp. powder

Graphical Abstract Highlight Research 1. FPH and Chlorella sp. microalgae can be used as effervescent tablet ingredients received by panelists. 2. The mixture design method can determine the formula of effervescent tablets made from a combination of FPH and microalgae 3. The best percentage of FPH and microalgae in effervescent tablets was 5.873% and 9.127%. Abstract Effervescent tablets are a popular pharmaceutical dosage due to their ease of use and effectiveness in delivering active ingredients to consumers. In order to develop effervescent tablets that are more effective and highly nutritious, this research focuses on the use of Fish Protein Hydrolysate (FPH) and microalgae Chlorella sp. powder as the active ingredient. This research aims to optimize the effervescent tablet formulation in Sensory Acceptance. Formula optimization uses the Design Expert 13.0® program with the d-optimal mixture design method, which recommends 13 formula combinations with analysis of response: color, plant and fishy flavor, sweet taste, sour taste, aftertaste, hedonic, protein content, lipid content, water, and pH of effervescent tablets with a p-value &lt;0.05 indicates that the model results are significant. Evaluation of granules includes flow rate test, angle of repose test, compressibility test, and drying shrinkage test to meet the requirements. Evaluation of effervescent tablets includes size uniformity, weight uniformity, firmness, and dissolution time that meet the requirements. The proximate composition of FPH and Chlorella sp. powder consists of a protein content of 19.60% and 47.68%, a lipid content of 0.15% and 4.87%, a water content of 0.06% and 5.0%, and an ash content of 1.15% and 4.24%, respectively. In addition, Chlorella sp. powder consists of fiber (38.31%) and total flavonoids (2.69%). The optimal formula results obtained were with a composition of FPH 5.873% and Chlorella sp. powder 9.127%. The optimum formula of FPH and Chlorella sp. powder in effervescent tablets succeeded in increasing the acceptance of sensory attributes, including color response, plant aroma, fishy aroma, sweet taste, sour taste, aftertaste, hedonic, protein content, lipid content, and water content.

Development of Orodispersible Tablets with Solid Dispersions of Fenofibrate and Co-Processed Mesoporous Silica for Improved Dissolution.

Poor water solubility is an important challenge in the development of oral patient-friendly solid dosage forms. This study aimed to prepare orodispersible tablets with solid dispersions of a poorly water-soluble drug fenofibrate and a co-processed excipient consisting of mesoporous silica and isomalt. This co-processed excipient, developed in a previous study, exhibited improved flow and compression properties compared to pure silica while maintaining a high specific surface area for drug adsorption. Rotary evaporation was used to formulate solid dispersions with different amounts of fenofibrate, which were evaluated for solid state properties and drug release. The solid dispersion with 30% fenofibrate showed no signs of crystallinity and had a significantly improved dissolution rate, making it the optimal sample for formulation or orodispersible tablets. The aim was to produce tablets with minimal amounts of additional excipients while achieving a drug release profile similar to the uncompressed solid dispersion. The compressed formulations met the requirements for orodispersible tablets in terms of disintegration time, and the drug release from best formulation approximated the profile of uncompressed solid dispersion. Future research should focus on reducing the disintegration time and tablet size to enhance patient acceptability further.

A novel water‐in‐water emulsion drag reducer with instant solubility and viscosity enhancement for slickwater fracturing fluid

AbstractDrag reducers are indispensable components of slickwater fracturing fluids and play a pivotal role in the reconstitution of unconventional oil and gas reservoirs. Water‐in‐water emulsion (W/W) drag reducers have garnered significant attention owing to their rapid dissolution and environmentally benign properties. The solubility and viscosity enhancing ability of W/W drag reducers were further enhanced by synthesizing a novel W/W drag reducer through dispersion polymerization, thereby meeting the requirements of real‐time mixed fracturing construction technology. The solubility, viscosity enhancement, and synthesis state of the synthetic drag reducer were employed as evaluation criteria, whereby the synthetic systems underwent screening and optimization of the synthesis conditions. The final synthetic conditions were determined as follows: the monomer (AM and DMC) had a total mass concentration of 25 wt%, with an AM to DMC molar ratio of 95:5. The dispersion medium (sodium sulfate and sodium chloride) had a total mass concentration of 12 wt%, with a sodium sulfate to sodium chloride mass ratio of 1:2. The dispersion stabilizer PVP K60 had a mass concentration of 7 wt%. The initiator had a total mass concentration of 0.05 wt%, with an ammonium persulfate to sodium bisulfite mass ratio of 1:1. The reaction was conducted at 35°C and a stirring speed of 500 r min−1 for a duration of 8 h. The successful synthesis of the polymer was demonstrated using Fourier transform infrared spectroscopy. Environmental scanning electron microscopy and atomic force microscopy have characterized that the drag reducer has good viscosity enhancement potential. The performance evaluation results show that the solid content of drag reducer was 32.68%, and the residue content was 11.70 mg L−1. The viscosity enhancement rate of 1.3 wt% drag reducer was 93.7%. The dissolution time of 0.1 wt% drag reducer was only 25 s. The drag‐reduction rate of drag reducer reached 73.52%. Experimental results have proved that the drag reducer has the advantages of instant solubility, appreciable viscosity enhancement and drag‐reduction efficiency, fully meeting the real‐time mixing fracturing construction conditions, improving construction efficiency, and reducing construction costs. We expect that this study can broaden the application of W/W drag reducers in unconventional reservoir and provide a theoretical basis for field applications.

Oral fast dissolving films made with alginate and whey protein for resveratrol delivery

Resveratrol is a natural polyphenol with low bioavailability because of poor hydro-solubility and extensive first-pass effect. The delivery to oral mucosa via oral fast dissolving films (OFDFs) is a useful administration route to bypass the first-pass metabolism through direct adsorption into the systemic circulation. In this study, the OFDFs was fabricated with loading of excessive and soluble resveratrol in various ratios of whey protein isolate (WPI) and alginate. The solubility of resveratrol was improved in the presence of WPI and/or alginate, which was further affected by glycerol. The OFDFs were characterized in term of thickness, disintegration time, intermolecular interaction, structure, mechanical properties and thermal degradation. At a glycerol/biopolymer ratio of 1:2 and the WPI/alginate ratios between 5:1 and 1:1, the OFDFs disintegrated within 30 s and completely dissolved within 60 s, containing 30–50 μg/cm2 dissolved resveratrol in water. The permeation percentage of 89% was the most at the WPI/alginate ratio of 3:1. Oral mucosa permeation of resveratrol in OFDFs was significantly greater than that in the corresponding film solution. The films exhibited fast disintegration and promotion of resveratrol permeation. These results demonstrate that WPI and alginate were effective in the preparation of OFDFs for enhancing the permeability of resveratrol. It is thus suggested that biopolymer-based OFDFs are potential carriers for oral delivery of polyphenols.

Physicochemical characterization of novel okra mucilage/hyaluronic acid-based oral disintegrating films for functional food applications

Oral disintegrating films (ODFs) offer a patient-friendly approach with enhanced convenience and rapid onset of action over various health benefits. ODFs are fabricated for geriatric, pediatric, and individuals facing swallowing challenges. The present work aims to fabricate and characterize ODFs mainly composed of okra mucilage (OM), hyaluronic acid (HA), vitamin-C-loaded bioactive glass nanoparticles (VBG NPs), and clove essential oil. A bio-inspired method was employed to synthesize VBG NPs using fructose template. The nutrient analysis of OM depicted that it is a rich source of protein, carbohydrates, magnesium, and flavonoids (quercetin), accounting for its antioxidant activity. The physicochemical characteristics of the ODFs studied using contact angle measurement, surface pH, opacity, and in vitro disintegration time revealed that ODFs disintegrated rapidly in simulated saliva. The neutral surface pH of ODFs indicates their non-irritant behaviour to the oral mucosa. VBG NPs and essential oil (EO) addition enhance the thermal and mechanical properties. Further, EO infusion in the film matrix resulted in the porous and antibacterial nature of the functional film as revealed by FE-SEM micrographs and antibacterial disk diffusion assay respectively. The obtained novel nutrient-rich ODF is hemocompatible with a hemolysis rate (HR%) <5 % and suitable for functional food applications.

Conversion of WastePaper into Dissolving Pulp: A Path for Circular Bioeconomy

AbstractFollowing the circular bioeconomy concept, this work studies the potential of an industrial wastepaper residue as an alternative raw material for dissolving pulp‐grade production. Prehydrolysis‐kraft cooking (PHK), elemental chlorine‐free (ECF) bleaching, and acid‐washing treatments were applied to achieve that aim. Considering the high lignin and hemicellulose content of the raw material, it was submitted to PHK pulping to enhance its cellulose content by removing those components. This processing resulted in a remarkable increase of 84 % in pulp Fock reactivity (from 45.6 % to 84.1 %). The dissolution extension and time in solvent systems LiCl/DMAc and NMMO/H2O were discussed regarding the pulp physicochemical properties. The dissolving pulp produced under this work showed great potential as raw material for textile applications, particularly highlighting the innovative process developed to improve its solubility.